TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/19/05 18:46 | 4/15/05 | BPA | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Lehman Leah M | IL | O | VP,Prod. | S.m | -304 | 3.78 | 0 | -80 | -100 | 0 | D | ||||||||||||||
4/18/05 19:23 | 4/14/05 | BPA | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Lehman Leah M | IL | O | VP,Prod. | S | -118 | 4.03 | 0 | -29 | -27 | 80 | D | ||||||||||||||
12/2/04 20:34 | 11/30/04 | BPA | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Lehman Leah M | IL | O | VP,Clini | S | -504 | 10.07 | 0 | -50 | -31 | 110 | D | ||||||||||||||
8/6/03 17:37 | 8/4/03 | BISP | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Lehman Leah M | IL | O | VP,Clini | P.d | 2 | 2.15 | 0 | 1 | 1 | 160 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |